Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life: Results in Dutch Patients and Review of the Literature.

Saved in:
Bibliographic Details
Title: Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life: Results in Dutch Patients and Review of the Literature.
Authors: Slot S; Department of Haematology, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: s.slot@vumc.nl., Raymakers RAP; Department of Haematology, University Medical Center Utrecht, Utrecht, The Netherlands., Schaap N; Department of Haematology, Radboud University Medical Centre Nijmegen, Nijmegen, The Netherlands., Span LFR; Department of Haematology, University Medical Center Groningen, Groningen, The Netherlands., Koene HR; Department of Haematology, St Antonius Hospital, Nieuwegein, The Netherlands., Kersting S; Department of Haematology, Haga Hospital, Den Haag, The Netherlands., Te Boekhorst PAW; Department of Haematology, Erasmus Medical Center, Rotterdam, The Netherlands., Westerman M; Department of Haematology, Northwest Clinics, Alkmaar, The Netherlands., Schouten HC; Department of Haematology, Academisch Ziekenhuis Maastricht, Maastricht, The Netherlands., Zweegman S; Department of Haematology, VU University Medical Center, Amsterdam, The Netherlands.
Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2019 Oct; Vol. 19 (10), pp. 624-634. Date of Electronic Publication: 2019 Jul 15.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first